This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The clinical results demonstrated that STEQEYMA and its reference product, ustekinumab, are highly similar, and have no clinically meaningful differences in terms of safety and efficacy. immunology market.” “STEQEYMA is now the latest biologic in our immunology portfolio, joining ZYMFENTRA (infliximab-dyyb). .
Having a thorough understanding of the dermatology and plastic surgery procedures, in addition to all new and modern cosmetic procedures on the market, is critical in assisting your clients in answering questions. A complete system must be in place per office, for the role of every action within the practice.
Restem’s ULSC therapy has shown promising results in early clinical trials, demonstrating safety, tolerability and initial clinically significant improvements, as well as the potential to significantly reduce the need for steroid use in patients. The company is currently preparing for Phase 2/3 trials with anticipated initiation in 1Q 2025.
It was very encouraging in the ReNeu trial to see that Gomekli provided deep and durable responses, with a manageable safety profile that enabled patients to stay on therapy. Gomekli demonstrated a manageable safety and tolerability profile.
This is a great milestone for our team, as we continue to examine the acne market, we believe there is still a high unmet need by patients for an acne product like XYNGARI, says Gerry Proehl, Dermatas Chairman, President, and Chief Executive Officer, in a news release.
The CRL did not identify any deficiencies related to the clinical efficacy or clinical safety data in the BLA, and the FDA did not request any new clinical trials or clinical data to support the approval of pz-cel. The BLA for pz-cel was accepted for filing and granted priority review designation by the FDA in November 2023.
Marketing Authorization Application. About the MIRA trial The MIRA trial (M1095-HS-201) is a global, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of the Nanobody sonelokimab, administered subcutaneously, in the treatment of adult patients with active moderate-to-severe hidradenitis suppurativa.
Launching Uzpruvo at the earliest opportunity in Europe’s largest pharmaceutical markets, promotes access by creating competition,” says STADA CEO Peter Goldschmidt in a news release. We are delighted at the launch of Uzpruvo in Europe and to be first-to-market,” adds Robert Wessman, Chief Executive Officer of Alvotech.
This tip ensures a controlled treatment environment, increasing treatment efficacy and patient safety. Wang, MD, MBE, MBA, who is the Medical Director of Laser & Skin Surgery Center of Pennsylvania and Medical Research Director at the office of Roy Geronemus, MD.
While both low-concentration and high-concentration strength biosimilars of Humira are marketed in the U.S. “The approval of SIMLANDI marks the first high-concentration, citrate-free biosimilar to Humira with IC status,” says Dr. Eric Hughes, Executive Vice President Global R&D and Chief Medical Officer at Teva, in a news release.
They also have advice from a body called the scientific committee for cosmetic safety or SCCS, which is composed largely of academics with an interest in medicine and general science. This is a simply enormous database of every cosmetic formulation on the market along with its pack copy. Smaller producers? Not so much.
Consider your target market as well. Understanding your target audience will help you tailor your services, pricing, and marketing strategies to attract and retain clients. Develop a comprehensive business plan With your spa concept and target market in mind, it’s time to create a detailed business plan.
Consider your target market as well. Understanding your target audience will help you tailor your services, pricing, and marketing strategies to attract and retain clients. Develop a comprehensive business plan With your spa concept and target market in mind, it’s time to create a detailed business plan.
Marketing Authorization Application. Two global, randomized, double blind, placebo-controlled trials are planned (IZAR-1 and IZAR-2) to evaluate the efficacy and safety of the nanobody sonelokimab over one year.
At Art of Dermatology at the Laser and Skin Surgery Center of New York, patient safety and satisfaction is Dr. Jessica Krant’s primary concern. Making sure you are seeing a board-certified core cosmetic specialty physician (dermatologist, plastic surgeon, oculoplastic surgeon, or ENT facial plastic surgeon) in a real medical office is key.
MediWound Ltd’s EscharEx bested market leader collagenase Santyl ointment in wound debridement, promotion of granulation tissue, and time to wound closure in patients with chronic venous leg ulcers (VLU). The safety profile and overall incidence of adverse wound reactions were comparable between arms. days for EscharEx vs. 76.0
Tim Raducha-Grace Named Chief Platform Officer at Zerigo Health Tim Raducha-Grace is the new Chief Platform Officer at Zerigo Health, a connected phototherapy platform that couples a handheld Narrow-band ultraviolet B (NB-UVB) light device with a smartphone app and team of care providers to allow patients to treat psoriasis and eczema at home.
Everyone from hotels to oil companies has participated in greenwashed marketing. When fraudulent, deceptive, or even just exaggerated environmental, health, and safety claims are made in the marketing of a product, that’s greenwashing. What is Greenwashing? Greenwashing is not a new tactic.
seeking Food and Drug Administration approval for the use of YCANTH for the treatment of common warts, but may also be utilized by Verrica to seek future marketing authorizations in territories outside the U.S. and Japan, including potentially within the European Union.”
There is a new dermal filler on the market! Juvéderm’s® newest filler, Volux , has been approved by the FDA and is set to hit medical offices in early 2023. This new filler is designed to specifically target the jawline, an area of concern for many consumers seeking facial sculpting and contouring.
Ted Lain, MD, MBA, board-certified dermatologist and Chief Medical Officer, Sanova Dermatology, Austin, Texas. More frequent patient office visits can also be better for the practice because of the opportunity to discuss other products or procedures, he said. “I But maybe it just takes some time for that to mature in the market.”
Career opportunities for licensed massage therapists are diverse, spanning from spas to clinical settings, such as chiropractic offices and hospitals. With these certifications, estheticians can perform more advanced treatments, enhancing their credentials and marketability. Check out the accredited Massage Therapist program at NASI.
“Through our innovative device and technologies, we are confident that Trufacial customers will experience the optimal at-home skincare to address their individual cosmetic concerns and maintain favorable outcomes from in-office treatments.” Perfect Corp. Expands AI Skin Simulation Technology Perfect Corp.
Benzoyl Peroxide-based acne medications can become unstable and form benzene, a known human carcinogen, according to new research from Valisure, an independent laboratory focused on testing the purity and safety of pharmaceutical drugs and consumer products. Food and Drug Administration (FDA).
Both drugs come from the Danish pharmaceutical company Novo Nordisk, whose market capitalization has soared to $609 billion, surpassing Tesla’s valuation by $40 billion. According to an article by the American Society of Plastic Surgeons: 15 "A new trend is taking shape in the offices of many plastic surgeons.
But the authors also noted that “further studies are needed to assess the long-term efficacy and safety of this technique.” Says Dr. Hartman, the lack of safety data and FDA approval are what make exosomes in serums and creams such a contentious trend. freeze) them. Hartman refers to exosomes as "the AI of skin care."
milligrams per day, slightly less than the recommendation, according to the Office of Dietary Supplements. While there are several chelated zinc supplements on the market, one of the best options is NOW Foods’ Zinc Glycinate softgels. Zinc dosage for senior: Men over age 60 do not usually meet their recommended daily zinc needs.
Some cosmetics companies are marketing estrogen-infused face creams and serums to people in menopause. Because of these potential safety concerns and the lack of evidence of benefit, Dr. Watchmaker and the other dermatologists recommended not using estrogen as skin care until more research is done. Do they work? What actually works?
It’s pure commonsense ,” Nathan Jones, chief executive officer of Xlear said in a statement. The pharmacology, toxicity, and safety data for NO use in humans has been well-established for decades. There is a growing body of data that sprays, in particular Xlear, can help combat the COVID-19 pandemic. the South-African or B.1.351,
Kanter will perform many of these tests at her office, and helps patients customize their diet. We're also seeing complete cleaning of the dentinal tubules … down to the microtubules as well … There's one more technology on the market that's reaching a lot of endodontists.
I recently met again with a consortium of federal agencies, the Office of Assistant Secretary of Health, the Environmental Protection Agency, the White House Council of Environmental Quality, to make the push to implement what the Food and Drug Administration has already said, which is to end amalgam for children and pregnant women.
Jashin Wu, MD, founder and CEO of the Dermatology Research and Education Foundation in San Diego, CA, says that more psoriasis patients will see improvements in their condition due to the influx of new agents and biosimilars on the market. It has great efficacy and safety and is oral… [This means] no shot and no risk of anaphylaxis.”
The EU Medical Device Regulation (MDR) certification gave its nod to four injectable hyaluronic acid (HA) gel fillers from Evolus under the brand name Estyme, The CE Mark certification, through the new MDR process, represents more stringent requirements, designed to ensure the safety, efficacy, and quality of medical devices sold in Europe.
This milestone represents an exciting new chapter in our long-term strategy to expand our portfolio and transition from a single-product company to a multi-product innovator, strengthening our leadership in performance beauty, says David Moatazedi, President and Chief Executive Officer of Evolus, in a news release. market in Q2 2025.
We are thrilled that the initial distribution to pharmacies is ongoing and the first Emrosi prescriptions have been filled, says Claude Maraoui, Co-Founder, President and Chief Executive Officer of Journey Medical, in a news release.
We are thrilled to announce this agreement with Kaken, a dermatology leader with significant reach and expertise in the Japanese market, says Martin Babler, President and Chief Executive Officer of Alumis, in a news release. Learn more about ESK-001 in psoriasis With Dr.Andrew Blauvelt here.
Every product is clean, non-toxic, and created to work harmoniously with in-office aesthetic treatments. 2 Game-Changing Ingredients for Real Results Unlike many mainstream skincare brands that prioritize marketing over efficacy, Epicutis is grounded in medical science.
Liu and Bui go on to conclude their study with a fair assessment of our growing market. Both teams say that the model neural network looks promising, however, more rigorous assessments of its safety would need to be made before such a program could go public. Says Ann Zyto, Chief Executive Officer at Medicoo. “We
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content